Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care

Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X:

“Cancer trial participation not associated with longer OS compared to routine care.

Motivation for patients:

• Potential benefits other than OS eg structured care protocols.
• To contribute to a better treatment for FUTURE patients.”

Additional information.
Source: Matthias Guckenberger/X